Market Place
Sourcing Support
FibroBiologics Files Patent for Cell Therapeutic for Splenomegaly
19 Nov 2024 //
GLOBENEWSWIRE
FibroBiologics Files Patent for Blood Clot Reduction in Therapies
14 Nov 2024 //
GLOBENEWSWIRE
FibroBiologics Updates on Artificial Thymus Organoid Technology
29 Oct 2024 //
GLOBENEWSWIRE
FibroBiologics to Present at ThinkEquity and BIO-Europe 2024
28 Oct 2024 //
#N/A
FibroBiologics, Charles River Collaborate on Cell Therapies
18 Oct 2024 //
GLOBENEWSWIRE
FibroBiologics Patent For Fibroblast Delivery Of Tumor Agents
16 Oct 2024 //
GLOBENEWSWIRE
FibroBiologics To Participate In Maxim Healthcare Summit
11 Oct 2024 //
GLOBENEWSWIRE
FibroBiologics to Present at 2024 Cell & Gene Meeting on the Mesa
30 Sep 2024 //
GLOBENEWSWIRE
FibroBiologics Engages Southern Star Research as CRO in Australia
19 Sep 2024 //
GLOBENEWSWIRE
FibroBiologics Files Patent For Hematopoietic Organoids Technology
12 Sep 2024 //
GLOBENEWSWIRE
FibroBiologics To Present At HC Wainwright Investment Conference
06 Sep 2024 //
GLOBENEWSWIRE
FibroBiologics Files Patent For Wound Healing Bandage With Fibroblast Tech
20 Aug 2024 //
GLOBENEWSWIRE
FibroBiologics Files 2024 Second Quarter Report
07 Aug 2024 //
GLOBENEWSWIRE
FibroBiologics to Present at JonesTrading Healthcare Summit 2024
15 Jul 2024 //
GLOBENEWSWIRE
FibroBiologics Announces Preliminary Proof for Artificial Thymus Organoid
25 Jun 2024 //
GLOBENEWSWIRE
FibroBiologics Set to Join Russell 2000® Index
13 Jun 2024 //
GLOBENEWSWIRE
FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024
06 Jun 2024 //
GLOBENEWSWIRE
FibroBiologics Announces 2024 Annual Meeting of Stockholders
15 May 2024 //
GLOBENEWSWIRE
FibroBiologics Files 2024 First Quarter Report
14 May 2024 //
GLOBENEWSWIRE
FibroBiologics to Present at the BIO International Convention 2024
07 May 2024 //
GLOBENEWSWIRE
FibroBiologics Discusses Opportunities to Work with Charles River
25 Apr 2024 //
GLOBENEWSWIRE
FibroBiologics Granted Australian Patent For Cartilage Regeneration
11 Apr 2024 //
GLOBENEWSWIRE
FibroBiologics Presents Data at Advanced Wound Care Summit USA
04 Apr 2024 //
GLOBENEWSWIRE
FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes Treatment
19 Mar 2024 //
PRESS RELEASE
FibroBiologics to Present at Advanced Wound Care Summit USA
13 Mar 2024 //
PRESS RELEASE
FibroBiologics Appoints Ruben A. Garcia as General Counsel
06 Mar 2024 //
PRESS RELEASE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.